title: Blood-pool magnetic resonance imaging contrast agents. New developments.
authors.affiliation: Laboratoire Guerbet, France.
authors.forename: D
authors.initials: D
authors.lastname: Doucet
authors.forename: E
authors.initials: E
authors.lastname: Urvoas
authors.forename: R
authors.initials: R
authors.lastname: Kravtzoff
authors.forename: C
authors.initials: C
authors.lastname: Chambon
authors.forename: E
authors.initials: E
authors.lastname: Schoumann-Claeys
authors.forename: G
authors.initials: G
authors.lastname: Frija
authors.forename: C
authors.initials: C
authors.lastname: Ropars
mesh_terms: D000818:Animals; D002860:Chromium Radioisotopes; D003287:Contrast Media / Q000493:pharmacokinetics; D004353:Drug Evaluation, Preclinical; D004355:Drug Stability; D004905:Erythrocyte Aging / Q000187:drug effects; D004912:Erythrocytes / Q000000981:diagnostic imaging; D005682:Gadolinium / Q000097:blood; D006571:Heterocyclic Compounds / Q000097:blood; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D051379:Mice; D009942:Organometallic Compounds / Q000097:blood; D011877:Radionuclide Imaging
chemical_list: D002860:Chromium Radioisotopes; D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium